Viatris Healthcare Limited
PolandAll drugs from this manufacturer
-
It is used on the skin for the treatment of acne in individuals over 12 years of age.
Dosage form: gel
Active substance Dosage clindamycin 10 mg/g tretinoin 0.25 mg/g ATC: D10AF51
-
It is used for skin treatment in acne in individuals over 12 years of age. It contains substances that inhibit the growth of bacteria responsible for acne and assist in the proper desquamation of skin cells.
Dosage form: gel
Active substance Dosage clindamycin 10 mg/g tretinoin 0.25 mg/g ATC: D10AF51
-
The medicine is used topically on the skin for the treatment of acne in individuals over 12 years of age.
Dosage form: gel
Active substance Dosage clindamycin 10 mg/g tretinoin 0.25 mg/g ATC: D10AF51
-
It is used in the treatment of Ménière's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea and vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC: N07CA01
-
It is used in the treatment of Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC: N07CA01
-
It is used to relieve symptoms of bladder instability, such as sudden urgency to urinate, urinary incontinence, or difficulty urinating. In children over 5 years of age, it also helps in cases of nocturnal enuresis (bedwetting) when other treatment methods have not been effective.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to treat, among other things, painful menstruation, endometriosis, irregular or excessively heavy periods, premenstrual syndrome, and infertility caused by low progesterone levels. It may also be used to reduce the risk of miscarriage and as part of hormone replacement therapy (HRT) for menopausal symptoms.
Dosage form: tablets, film-coated
Active substance Dosage dydrogesterone 10 mg ATC: G03DB01
-
The medicine is used to treat symptoms of irritable bowel syndrome, such as abdominal pain and cramps, bloating, diarrhea, constipation, or small, hard stools.
Dosage form: capsules, extended release, hard
Active substance Dosage mebeverine hydrochloride 200 mg ATC: A03AA04
-
The medicine is used to treat symptoms of irritable bowel syndrome, such as abdominal pain and cramps, bloating, diarrhea, constipation, or small, hard stools.
Dosage form: capsules, extended release, hard
Active substance Dosage mebeverine hydrochloride 200 mg ATC: A03AA04
-
The medicine is used to relieve the symptoms of moderate to severe seasonal and perennial allergic rhinitis. It helps with runny nose, sneezing, itching, and the sensation of nasal congestion.
Dosage form: spray, nasal suspension
Active substance Dosage azelastine hydrochloride 137 mcg fluticasone propionate 50 mcg ATC: R01AD58
-
It is used to relieve the symptoms of moderate to severe seasonal and perennial allergic rhinitis. It helps with runny nose, sneezing, itching, and the sensation of nasal congestion.
Dosage form: spray, nasal suspension
ATC: R01AD58
-
It is an anti-inflammatory medicine used to treat mild to moderate atopic dermatitis in patients aged 3 months and older. It is used in situations where topical steroids cannot be used or are not recommended (e.g., when applied to the face and neck, or in cases of steroid intolerance).
Dosage form: cream
Active substance Dosage pimecrolimus 10 mg/g ATC: D11AH02
-
The medicine is used to treat mild to moderate atopic dermatitis in patients aged 3 months and older, in situations where steroids cannot be used or are not recommended.
Dosage form: cream
Active substance Dosage pimecrolimus 10 mg/g ATC: D11AH02
-
It is an anti-inflammatory drug used in the treatment of mild to moderate atopic dermatitis in patients aged 3 months and older. It is used in situations where steroids cannot be used or are not recommended (e.g., when applied to the face and neck or when there is an intolerance to steroids).
Dosage form: cream
Active substance Dosage pimecrolimus 10 mg/g ATC: D11AH02
-
It is an anti-inflammatory drug used in the treatment of mild to moderate atopic dermatitis in patients aged 3 months and older. It is used in situations where steroids (glucocorticoids) cannot be used or are not recommended.
Dosage form: cream
Active substance Dosage pimecrolimus 10 mg/g ATC: D11AH02
-
The medicine is used in life-threatening situations for the immediate treatment of sudden, severe allergic reactions (anaphylaxis). This may occur as a result of contact with allergens in food, medications, insect stings, or due to physical exertion.
Dosage form: solution for injection in a syringe
Active substance Dosage epinephrine 150 mcg ATC: C01CA24
-
The medicine is used in life-threatening situations to treat sudden and severe allergic reactions (anaphylaxis). These may be caused, for example, by food, medication, or insect stings.
Dosage form: solution for injection in a syringe
Active substance Dosage epinephrine 0.3 mg/dose ATC: C01CA24
-
The medicinal product is used in the treatment of mild to moderate arterial hypertension, symptomatic heart failure, and left ventricular dysfunction following myocardial infarction.
Dosage form: capsules, hard
Active substance Dosage trandolapril 0.5 mg ATC: C09AA10
-
The medicine is used to treat mild or moderate arterial hypertension, symptomatic heart failure, and left ventricular dysfunction following a myocardial infarction.
Dosage form: capsules, hard
Active substance Dosage trandolapril 0.5 mg ATC: C09AA10
-
The medicine is used in the treatment of mild to moderate arterial hypertension, symptomatic heart failure, and left ventricular dysfunction following a myocardial infarction.
Dosage form: capsules, hard
Active substance Dosage trandolapril 2 mg ATC: C09AA10
-
The medicinal product is used to treat mild or moderate arterial hypertension, symptomatic heart failure, and left ventricular dysfunction following a myocardial infarction.
Dosage form: capsules, hard
Active substance Dosage trandolapril 4 mg ATC: C09AA10
-
The medicinal product is used in the treatment of mild to moderate arterial hypertension, symptomatic heart failure, and left ventricular dysfunction following myocardial infarction.
Dosage form: capsules, hard
Active substance Dosage trandolapril 4 mg ATC: C09AA10
-
The medicinal product is used in the treatment of mild to moderate arterial hypertension, symptomatic heart failure, and left ventricular dysfunction following myocardial infarction.
Dosage form: capsules, hard
Active substance Dosage trandolapril 4 mg ATC: C09AA10
-
The medicinal product is intended for the short-term treatment of insomnia in adults. It helps facilitate falling asleep, reduces the number of nighttime awakenings, prolongs sleep duration, and improves sleep quality and well-being upon waking.
Dosage form: tablets, film-coated
Active substance Dosage zopiclone 7.5 mg ATC: N05CF01
-
The medicine is used in adults, children, and adolescents for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and cardiac rhythm disorders, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, film-coated
Active substance Dosage verapamil hydrochloride 40 mg ATC: C08DA01
-
It is used in adults, children, and adolescents for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and cardiac rhythm disorders, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, film-coated
Active substance Dosage verapamil hydrochloride 40 mg ATC: C08DA01
-
The medicine is intended for adults, children, and adolescents for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, film-coated
Active substance Dosage verapamil hydrochloride 80 mg ATC: C08DA01
-
The medicinal product is used in adults for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and certain cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
The medicine is used in adults for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
The medicine is used in adults for the treatment of arterial hypertension, coronary artery disease (e.g., angina pectoris), and cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
The medicine is used in adults for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
The medicine is used in adults for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and certain cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
It is used in adults for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and certain cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
The medicinal product is used in adults for the treatment of arterial hypertension, coronary artery disease (including angina pectoris), and cardiac arrhythmias, such as paroxysmal supraventricular tachycardia or atrial fibrillation.
Dosage form: tablets, prolonged release
Active substance Dosage verapamil hydrochloride 240 mg ATC: C08DA01
-
The medicine is intended for adults and children over 12 years of age for the treatment of infections caused by bacteria. It is used, among other things, in cases of upper respiratory tract infections (e.g., sinusitis, sore throat), lower respiratory tract infections (e.g., pneumonia, bronchitis), acute otitis media, and skin and soft tissue infections.
Dosage form: tablets, modified release
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
This is an antibiotic used in adults and children over 12 years of age to treat infections caused by susceptible bacteria. This includes, among others, upper and lower respiratory tract infections (e.g., pharyngitis, sinusitis, bronchitis, pneumonia), acute otitis media, and skin and soft tissue infections.
Dosage form: tablets, modified release
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
This is an antibiotic used in adults and children over 12 years of age to treat infections caused by bacteria. This includes, among others, upper respiratory tract infections (e.g., sore throat, sinusitis), lower respiratory tract infections (e.g., bronchitis, pneumonia), acute otitis media, and skin and soft tissue infections.
Dosage form: tablets, prolonged release
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
It is intended for the treatment of bacterial infections in adults and children over 12 years of age. It is used, among other things, in cases of upper respiratory tract infections (e.g., sinusitis, sore throat), lower respiratory tract infections (e.g., pneumonia, bronchitis), acute otitis media, and skin and soft tissue infections.
Dosage form: tablets, modified release
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
The medicine is intended for adults and children over 12 years of age for the treatment of infections caused by bacteria. It is used, among others, in cases of throat, sinus, bronchial, lung, and middle ear infections, as well as skin and soft tissue infections.
Dosage form: tablets, prolonged release
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
The medicine is used in children, adolescents, and adults for digestive disorders resulting from pancreatic insufficiency (e.g., in cystic fibrosis, chronic pancreatitis, or after pancreatic or gastric surgery). It helps digest food, reduces abdominal pain and bloating, and improves stool consistency.
Dosage form: capsules, hard, intestinal
ATC: A09AA02
-
The medicine is used in children, adolescents, and adults for digestive disorders resulting from pancreatic insufficiency (when the pancreas does not produce sufficient enzymes). This may apply to individuals with cystic fibrosis, chronic pancreatitis, pancreatic cancer, after removal of the pancreas or stomach, and in other clinical conditions.
Dosage form: capsules, hard, intestinal
Active substance Dosage pancreatin 10 000 j. ATC: A09AA02
-
The medicine is used in children, adolescents, and adults for digestive disorders resulting from pancreatic insufficiency. It may help in conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after the removal of part of the pancreas or stomach. It helps to reduce abdominal pain and bloating and improves stool consistency.
Dosage form: capsules, hard, intestinal
Active substance Dosage pancreatin 10 000 j. ATC: A09AA02
-
The medicine is used in case of digestive disorders resulting from pancreatic insufficiency (when the pancreas does not produce a sufficient amount of enzymes). It helps digest food, reduces abdominal pain and bloating, and improves stool consistency.
Dosage form: capsules, hard, intestinal
Active substance Dosage pancreatin 10 000 j. ATC: A09AA02